Tectonic Therapeutic (TECX) Long-Term Deferred Tax (2017 - 2018)
Tectonic Therapeutic (TECX) reported Long-Term Deferred Tax of $238000.0 for Q4 2018, up 1090.0% year-over-year from $20000.0 in Q4 2017, and up 1090.0% quarter-over-quarter from $20000.0 in Q4 2017.
Tectonic Therapeutic (TECX) Long-Term Deferred Tax (2017 - 2018) Analysis & Trends
Tectonic Therapeutic (TECX) has 2 years of Long-Term Deferred Tax data on file, last reported at $238000.0 in Q4 2018.
- Long-Term Deferred Tax for Q4 2018 came in at $238000.0, up 1090.0% year-over-year; the trailing twelve-month figure through Dec 2018 was $238000.0 (up 1090.0% YoY), and the FY2018 annual result was $238000.0, up 1090.0% from the prior year.
- Long-Term Deferred Tax grew to $238000.0 in Q4 2018 per TECX's latest filing, from $20000.0 in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $238000.0 in Q4 2018 and troughed at $20000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 238,000.00 |
| Dec 31, 2017 | 20,000.00 |